Ocular Therapeutix logo
Ocular Therapeutix OCUL
$ 8.53 0.89%

Квартальный отчет 2024-Q3
добавлен 14.11.2024

report update icon

Ocular Therapeutix Мультипликаторы 2011-2024 | OCUL

Мультипликаторы по годам Ocular Therapeutix

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-9.6 -6.1 -81.3 -8.1 -2.3 -2.4 -2.7 -3.6 -3.6 -11.3 - - -

P/S

13.3 8.4 12.2 72.3 47.0 73.0 88.3 84.7 81.3 420.6 - - -

EPS

-1.0 -0.9 -0.1 -2.6 -1.9 -1.6 -2.2 -1.8 -1.7 -2.7 -5.1 -5.6 -

EV (Enterprise Value)

742 млн 444 млн 485 млн 1.22 млрд 227 млн 128 млн 157 млн 150 млн 132 млн 307 млн -13.2 млн -17.8 млн -

EBITDA per Share

-0.99 -1 -0.99 -0.99 -1.84 -1.49 -2.09 -1.71 -1.61 -2.49 - - -

EV/EBITDA

-5.4 -18.4 -2.3 -2.0 -2.4 -3.4 -3.4 -11.4 - - -

PEG

2.11 0.6 13.9 1.75 0.11 -0.08 0.12 0.68 -0.1 0.06 - - -

P/B

8.5 12.2 6.1 16.5 -54.8 4.0 6.5 3.1 1.6 5.5 - - -

P/CF

-11.1 -7.3 -8.1 -23.5 -2.5 -2.8 -2.9 -4.4 -4.0 -14.9 - - -

ROE %

-88.59 -200.79 -7.45 -204.53 2379.39 -167.19 -242.42 -85.95 -44.37 -48.81 - - -

ROA %

-32.03 -47.58 -3.20 -59.43 -109.69 -82.11 -114.35 -59.65 -36.03 -36.64 - - -

ROCE %

-90.40 -222.32 -88.68 -82.59 -128.62 -92.54 -147.42 -65.02 -36.40 -37.46 - - -

Current Ratio

1.6 1.3 1.8 1.4 5.0 6.1 3.2 8.4 19.9 13.0 - - -

DSO

148.3 150.5 140.0 155.2 220.0 36.9 42.9 48.4 40.3 155.6 - - -

DIO

147.9 129.6 101.5 188.8 149.8 170.3 97.4 93.1 153.3 533.5 - - -

DPO

328.7 390.5 302.4 523.7 513.0 2327.4 2852.1 1743.4 2239.2 5278.5 - - -

Операционный цикл

296.2 280.1 241.5 344.0 369.8 207.2 140.3 141.5 193.6 689.0 - - -

Финансовый цикл

-32.5 -110.4 -60.9 -179.7 -143.3 -2120.2 -2711.8 -1602.0 -2045.6 -4589.4 - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Ocular Therapeutix

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.22 -0.26 -0.49 - -0.01 -0.26 -0.39 - -0.31 -0.24 -0.16 - 0.03 -0.11 0.04 - -0.19 -0.64 -0.41 -0.53 -0.4 -0.57 -0.41 -0.42 -0.38 -0.37 -0.4 -0.44 -0.54 -0.64 -0.58 -0.52 -0.39 -0.46 -0.44 -0.43 -0.47 -0.45 -0.35 -0.37 -0.48 -2.1 -2.45 -1.32 -1.34 -1.19 -1.26 - - - - - - - -

EBITDA per Share

- - -0.23 - - - -0.29 - -0.26 -0.24 -0.23 - -0.23 -0.25 -0.26 - -0.19 -0.29 -0.31 -0.43 -0.45 -0.48 -0.45 -0.42 -0.34 -0.33 -0.37 -0.43 -0.48 -0.61 -0.56 -0.5 -0.35 -0.43 -0.42 -0.42 -0.43 -0.42 -0.32 -0.35 -0.42 -1.87 -2.35 -1.28 -1.2 -1.08 - - - - - - - - -

ROE %

-44.42 -40.63 -699.01 -988.74 -1041.07 -1086.82 -445.37 -96.56 -93.52 -38.15 -20.20 -3.78 -19.48 -38.22 -75.71 -92.02 624.70 1157.70 1879.39 2379.39 1614.17 1055.03 342.92 -167.19 -168.80 -186.49 -219.51 -242.42 -216.97 -175.88 -126.39 -85.95 -73.17 -67.59 -56.75 -44.37 -46.05 -45.61 -45.33 -48.81 -29.36 -11.01 5.07 17.01 11.12 5.20 - - - - - - - - -

ROA %

-28.26 -21.13 -29.54 -40.77 -56.03 -70.96 -64.93 -32.78 -31.56 -15.09 -7.92 -1.17 -5.73 -11.51 -21.80 -26.74 -59.78 -79.07 -96.16 -109.69 -100.47 -97.17 -85.02 -82.11 -81.93 -89.46 -104.29 -114.35 -107.82 -92.55 -74.09 -59.65 -52.19 -49.83 -43.63 -36.03 -36.56 -35.44 -34.55 -36.64 -44.77 -53.84 -61.80 -52.84 -34.53 -16.14 - - - - - - - - -

ROCE %

-277.03 -508.63 -1163.43 -1143.21 -1189.82 -991.75 -355.67 -99.22 -121.58 -97.33 -92.28 -71.82 -90.23 -86.27 -84.57 -63.74 525.82 1181.80 1800.32 2363.69 1725.96 1047.08 414.26 -164.79 -165.25 -182.06 -214.39 -236.83 -212.17 -171.82 -123.04 -83.31 -70.79 -65.50 -54.90 -42.64 -44.02 -43.10 -42.47 -46.16 -27.55 -10.23 4.92 16.55 10.80 5.03 - - - - - - - - -

Current Ratio

3.5 3.7 4.1 1.6 1.1 1.0 1.1 1.3 1.4 1.6 1.7 1.8 1.7 1.5 1.5 1.4 1.4 1.4 1.4 1.0 1.0 1.0 1.0 2.0 2.0 2.0 2.0 1.9 1.9 1.9 1.9 3.3 3.3 3.3 3.3 5.3 5.3 5.3 5.3 4.0 4.0 4.0 4.0 4.5 4.5 4.5 - - - - - - - - -

DSO

178.8 157.6 162.8 - 154.0 145.5 144.8 - 153.6 162.5 153.4 - 143.7 126.0 160.8 - 190.3 712.5 258.8 103.1 280.5 357.7 254.9 36.4 36.8 28.3 57.3 42.4 39.4 47.1 45.7 44.6 23.9 - 19.2 40.0 37.5 51.3 72.9 59.5 209.9 309.5 978.4 - - - - - - - - - - - -

DIO

144.7 154.8 167.9 - 147.8 156.4 159.3 - 129.5 112.9 91.5 - 81.3 93.0 118.9 - 243.5 817.9 120.0 - 108.0 157.7 417.4 - 172.2 129.4 193.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

224.8 306.6 373.1 - 250.4 315.4 397.0 - 383.2 281.4 281.2 - 283.1 334.4 350.9 - 549.3 1844.8 333.0 - 370.0 540.2 2221.7 - 2352.7 1768.3 3727.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

323.6 312.4 330.7 - 301.8 301.9 304.2 - 283.1 275.4 244.9 - 225.0 219.1 279.7 - 433.8 1530.4 378.9 103.1 388.5 515.4 672.3 36.4 209.0 157.7 250.6 42.4 39.4 47.1 45.7 44.6 23.9 - 19.2 40.0 37.5 51.3 72.9 59.5 209.9 309.5 978.4 - - - - - - - - - - - -

Финансовый цикл

98.8 5.7 -42.3 - 51.4 -13.4 -92.9 - -100.1 -6.0 -36.2 - -58.0 -115.3 -71.2 - -115.5 -314.4 45.9 103.1 18.5 -24.8 -1549.4 36.4 -2143.7 -1610.6 -3476.9 42.4 39.4 47.1 45.7 44.6 23.9 - 19.2 40.0 37.5 51.3 72.9 59.5 209.9 309.5 978.4 - - - - - - - - - - - -

Все данные представлены в валюте USD